Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy : a multicenter phase II trial

To investigate the activity of docetaxel and granulocyte colony-stimulating factor support (G-CSF) in patients with advanced non-small-cell lung cancer (NSCLC) previously treated with cisplatin. A total of 60 patients with locoregional and metastatic NSCLC who had relapsed or progressed after first-...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer chemotherapy and pharmacology 1999, Vol.43 (3), p.257-262
Hauptverfasser:	ALEXOPOULOS, K, KOUROUSSIS, C, GEORGOULIAS, V, ANDROULAKIS, N, PAPADAKIS, E, VASLAMATZIS, M, KAKOLYRIS, S, SAMELIS, G, PATILA, E, VOSSOS, A, SAMANTAS, E
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic agents Antineoplastic Agents - therapeutic use Antineoplastic Agents, Phytogenic - administration & dosage Antineoplastic Agents, Phytogenic - adverse effects Antineoplastic Agents, Phytogenic - therapeutic use Biological and medical sciences Carcinoma, Non-Small-Cell Lung - drug therapy Chemotherapy Cisplatin - therapeutic use Dose-Response Relationship, Drug Drug Therapy, Combination Female Granulocyte Colony-Stimulating Factor - administration & dosage Granulocyte Colony-Stimulating Factor - therapeutic use Humans Lung Neoplasms - drug therapy Male Medical sciences Middle Aged Paclitaxel - administration & dosage Paclitaxel - adverse effects Paclitaxel - analogs & derivatives Paclitaxel - therapeutic use Pharmacology. Drug treatments Recombinant Proteins Survival Analysis Taxoids
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!